News2021-05-28T14:12:08+00:00
0812, 2020

Paragon Biosciences Appoints Kerensa Jimenez as Paragon Health Capital Chief Executive Officer

Paragon Biosciences Appoints Kerensa Jimenez as Paragon Health Capital Chief Executive Officer Chicago, August 12, 2020 – With strong momentum in its growing portfolio of life science companies, Paragon Biosciences announced the appointment of Kerensa Jimenez as the new chief executive officer of its capital markets group, Paragon Health Capital (PHC), a registered broker-dealer. With [...]

0723, 2020

Synthetic Protein Design and Production Publication Confirms Evozyne’s Revolutionary Technology

Synthetic Protein Design and Production Publication Confirms Evozyne’s Revolutionary Technology Publication in peer-reviewed journal Science demonstrates the foundation of the company’s evolution-based, data-driven engineering technology to build artificial functional enzymes Chicago, July 23, 2020 – A publication released in the peer-review journal Science today demonstrates the foundation of Evozyne’s evolution-based, data-driven engineering process for building [...]

063, 2020

Horizon Technology Finance and Emalex Biosciences Announce $15 Million Venture Loan Facility

Horizon Technology Finance and Emalex Biosciences Announce $15 Million Venture Loan Facility – Biopharmaceutical company advancing clinical research evaluating novel treatment for Tourette syndrome and childhood-onset fluency disorder – Farmington, Connecticut & Chicago, Illinois – June 3, 2020 – Horizon Technology Finance Corporation (NASDAQ: HRZN) (“Horizon”), a leading specialty finance company that provides capital [...]

Archives
Go to Top